Literature DB >> 15992893

Delayed onset bleomycin-induced pneumonitis.

I Uzel1, M Ozguroglu, B Uzel, K Kaynak, O Demirhan, C Akman, F Oz, M Yaman.   

Abstract

We describe a 39-year-old male patient who developed bleomycin-induced pneumonitis 2 years after completion of chemotherapy for nonseminomatous testicular cancer. Bleomycin sometimes causes fatal pulmonary toxicity, including bleomycin-induced pneumonitis. The central event in the development of pneumonitis is endothelial damage of the lung vasculature due to bleomycin-induced cytokines and free radicals. Pulmonary toxicity usually begins at bleomycin administration. The development of bleomycin-induced pneumonitis up to 6 months after bleomycin therapy has also been reported. We report a patient who developed bleomycin-induced pneumonitis 2 years after the initiation of bleomycin-containing chemotherapy regimens.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15992893     DOI: 10.1016/j.urology.2005.01.038

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  9 in total

Review 1.  Lung regeneration: a tale of mice and men.

Authors:  Maria C Basil; Edward E Morrisey
Journal:  Semin Cell Dev Biol       Date:  2019-11-21       Impact factor: 7.727

2.  Male sex hormones exacerbate lung function impairment after bleomycin-induced pulmonary fibrosis.

Authors:  James W Voltz; Jeffrey W Card; Michelle A Carey; Laura M Degraff; Catherine D Ferguson; Gordon P Flake; James C Bonner; Kenneth S Korach; Darryl C Zeldin
Journal:  Am J Respir Cell Mol Biol       Date:  2008-02-14       Impact factor: 6.914

3.  Acute fibrinous and organising pneumonia: a rare histopathological variant of chemotherapy-induced lung injury.

Authors:  Arjun Gupta; Shiraj Sen; Harris Naina
Journal:  BMJ Case Rep       Date:  2016-04-06

4.  Fibrotic Cystic Lung Disease Post Hematopoietic Stem Cell Transplant: Who is the Culprit?

Authors:  Walid Alam; Rayan Mohamad; Maysoun Koubaissi; Salwa A Koubaissi
Journal:  Clin Med Insights Case Rep       Date:  2022-05-13

5.  Pirfenidone as salvage treatment for refractory bleomycin-induced lung injury: a case report of seminoma.

Authors:  Koji Sakamoto; Satoru Ito; Naozumi Hashimoto; Yoshinori Hasegawa
Journal:  BMC Cancer       Date:  2017-08-07       Impact factor: 4.430

Review 6.  Pharmacological Threat to Lungs: A Case Series and Literature Review.

Authors:  Omar Irfan; Jaleed A Gilani; Abeel Irshad; Babar Irfan; Javaid A Khan
Journal:  Cureus       Date:  2017-05-09

7.  Bleomycin-induced pneumonitis in a young Ghanaian male with Hodgkin's Lymphoma.

Authors:  Yvonne A Dei-Adomakoh; Jane S Afriyie-Mensah; Hafisatu Gbadamosi
Journal:  Ghana Med J       Date:  2020-12

8.  Severe Acute Pulmonary Toxicity Associated with Brentuximab in a Patient with Refractory Hodgkin's Lymphoma.

Authors:  Yasmin Sabet; Saul Ramirez; Elizabeth Rosell Cespedes; Marimer Rensoli Velasquez; Mateo Porres-Muñoz; Sumit Gaur; Juan B Figueroa-Casas; Mateo Porres-Aguilar
Journal:  Case Rep Pulmonol       Date:  2016-04-17

Review 9.  Development of a best-practice clinical guideline for the use of bleomycin in the treatment of germ cell tumours in the UK.

Authors:  Robert A Watson; Hugo De La Peña; Maria T Tsakok; Johnson Joseph; Sara Stoneham; Jonathan Shamash; Johnathan Joffe; Danish Mazhar; Zoe Traill; Ling-Pei Ho; Sue Brand; Andrew S Protheroe
Journal:  Br J Cancer       Date:  2018-10-25       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.